The chemical substance known as "3-[(1S,2S)-1-[2-[[(4S)-3-(2,3-Dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5(2H)-one" (CAS 2212020-29-4) is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups such as oxadiazole, indole, and imidazole moieties. This compound exhibits potential biological activity, likely due to its diverse structural features that may interact with various biological targets. The presence of fluorine and multiple chiral centers suggests that it may possess specific stereochemical properties that could influence its pharmacological profile. Additionally, the compound's stability and solubility characteristics would be essential for its application in medicinal chemistry. Overall, this substance represents a sophisticated example of modern drug design, integrating various chemical functionalities to enhance efficacy and selectivity in therapeutic contexts.

3-[(1S,2S)-1-[2-[[(4S)-3-(2,3-Dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5(2H)-one

2212020-29-4: The chemical substance known as "3-[(1S,2S)-1-[2-[[(4S)-3-(2,3-Dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5(2H)-one" (CAS 2212020-29-4) is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups such as oxadiazole, indole, and imidazole moieties. This compound exhibits potential biological activity, likely due to its diverse structural features that may interact with various biological targets. The presence of fluorine and multiple chiral centers suggests that it may possess specific stereochemical properties that could influence its pharmacological profile. Additionally, the compound's stability and solubility characteristics would be essential for its application in medicinal chemistry. Overall, this substance represents a sophisticated example of modern drug design, integrating various chemical functionalities to enhance efficacy and selectivity in therapeutic contexts.

CAS 2212020-29-4

3-[(1S,2S)-1-[2-[[(4S)-3-(2,3-Dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcyclopropyl]-1,2,4-oxadiazol-5(2H)-one

Orforglipron Impurity 1

Ref: 4Z-O-140004